open access

Vol 73, No 6 (2022)
Original paper
Submitted: 2022-04-12
Accepted: 2022-06-02
Published online: 2022-08-12
Get Citation

Curcumin protects islet beta cells from streptozotocin‑induced type 2 diabetes mellitus injury via its antioxidative effects

Jingling Duan12, Mingqing Yang34, Yi Liu34, Shengjun Xiao45, Xiaoling Zhang1
·
Pubmed: 35971926
·
Endokrynol Pol 2022;73(6):942-946.
Affiliations
  1. Department of Physiology, Faculty of Basic Medical Sciences, Guilin Medical University, Guilin, China
  2. Department of Pathology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  3. Graduate School of Guilin Medical University, Guilin, China
  4. Department of Pathology, the Second Affiliated Hospital, Guilin Medical University, Guilin, China
  5. Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, Guilin, China

open access

Vol 73, No 6 (2022)
Original Paper
Submitted: 2022-04-12
Accepted: 2022-06-02
Published online: 2022-08-12

Abstract

Streptozotocin (STZ)-induced diabetes rodent models are widely used to study the pathogenesis and metabolic function in diabetes (DM). The aim of this study was to assess the antioxidant effect of curcumin in STZ-induced type 2 diabetes mellitus (T2DM). In this research, rats were randomly divided into 3 groups (8 in each group): a nondiabetic group (Control), a diabetic group (DM), and a curcumin treatment group (DM + Cur 200 mg/kg group). Meanwhile, after intraperitoneal injection (i.p.), associated-oxidative stress parameters were observed, malondialdehyde (MDA) was decreased, and glutathione peroxidase (GPX) and super oxide dismutase (SOD) were restored in pancreatic tissues of curcumin-treated DM rats. In addition, curcumin improved the survival and function of islet cells with decreased cell apoptosis in Langerhans islet and increased insulin secretion in the STZ-induced T2DM rat model. Our findings suggest that curcumin is a potent candidate for the prevention and therapy of DM.

Abstract

Streptozotocin (STZ)-induced diabetes rodent models are widely used to study the pathogenesis and metabolic function in diabetes (DM). The aim of this study was to assess the antioxidant effect of curcumin in STZ-induced type 2 diabetes mellitus (T2DM). In this research, rats were randomly divided into 3 groups (8 in each group): a nondiabetic group (Control), a diabetic group (DM), and a curcumin treatment group (DM + Cur 200 mg/kg group). Meanwhile, after intraperitoneal injection (i.p.), associated-oxidative stress parameters were observed, malondialdehyde (MDA) was decreased, and glutathione peroxidase (GPX) and super oxide dismutase (SOD) were restored in pancreatic tissues of curcumin-treated DM rats. In addition, curcumin improved the survival and function of islet cells with decreased cell apoptosis in Langerhans islet and increased insulin secretion in the STZ-induced T2DM rat model. Our findings suggest that curcumin is a potent candidate for the prevention and therapy of DM.

Get Citation

Keywords

antidiabetic activity; antioxidant activity; curcumin; diabetes mellitus; pancreatic beta cell toxicity

About this article
Title

Curcumin protects islet beta cells from streptozotocin‑induced type 2 diabetes mellitus injury via its antioxidative effects

Journal

Endokrynologia Polska

Issue

Vol 73, No 6 (2022)

Article type

Original paper

Pages

942-946

Published online

2022-08-12

Page views

4075

Article views/downloads

390

DOI

10.5603/EP.a2022.0070

Pubmed

35971926

Bibliographic record

Endokrynol Pol 2022;73(6):942-946.

Keywords

antidiabetic activity
antioxidant activity
curcumin
diabetes mellitus
pancreatic beta cell toxicity

Authors

Jingling Duan
Mingqing Yang
Yi Liu
Shengjun Xiao
Xiaoling Zhang

References (29)
  1. Lowe J, Taveira-da-Silva R, Hilário-Souza E. Dissecting copper homeostasis in diabetes mellitus. IUBMB Life. 2017; 69(4): 255–262.
  2. Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016; 12(2): 73–81.
  3. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2020; 44(Supplement_1): S15–S33.
  4. Brekke HK, Jansson PA, Lenner RA, et al. Lifestyle changes can be achieved through counseling and follow-up in first-degree relatives of patients with type 2 diabetes. J Am Diet Assoc. 2003; 103(7): 835–843.
  5. Hekimsoy Z, Oktem IK. Duration of obesity is not a risk factor for type 2 diabetes mellitus, arterial hypertension and hyperlipidemia. Diabetes Obes Metab. 2003; 5(6): 432–437.
  6. Op de Beeck A, Eizirik DL. Viral infections in type 1 diabetes mellitus--why the β cells? Nat Rev Endocrinol. 2016; 12(5): 263–273.
  7. Qin Li, Knol MJ, Corpeleijn E, et al. Does physical activity modify the risk of obesity for type 2 diabetes: a review of epidemiological data. Eur J Epidemiol. 2010; 25(1): 5–12.
  8. Zhou Z, Xiang Y, Ji L, et al. LADA China Study Group. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study. Diabetes. 2013; 62(2): 543–550.
  9. Maiese K, Morhan SD, Chong ZZ. Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr Neurovasc Res. 2007; 4(1): 63–71.
  10. King AJF. The use of animal models in diabetes research. Br J Pharmacol. 2012; 166(3): 877–894.
  11. Bulboacă A, D Bolboacă S, Suci S. Protective effect of curcumin in fructose-induced metabolic syndrome and in streptozotocin-induced diabetes in rats. Iran J Basic Med Sci. 2016; 19(6): 585–593.
  12. Dai F, Chen WF, Zhou Bo, et al. Antioxidative effects of curcumin and its analogues against the free-radical-induced peroxidation of linoleic acid in micelles. Phytother Res. 2009; 23(9): 1220–1228.
  13. Motterlini R, Foresti R, Bassi R, et al. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med. 2000; 28(8): 1303–1312.
  14. Batinic-Haberle I, Tovmasyan A, Roberts ERH, et al. SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways. Antioxid Redox Signal. 2014; 20(15): 2372–2415.
  15. Zhang L, Wu M, Yu D, et al. Identification of Glutathione Peroxidase (GPX) Gene Family in and Gene Expression Analysis under Stress Conditions. Int J Mol Sci. 2018; 19(11).
  16. Ghonimi NAM, Elsharkawi KA, Khyal DSM, et al. Serum malondialdehyde as a lipid peroxidation marker in multiple sclerosis patients and its relation to disease characteristics. Mult Scler Relat Disord. 2021; 51: 102941.
  17. Palipoch S, Punsawad C, Koomhin P, et al. Hepatoprotective effect of curcumin and alpha-tocopherol against cisplatin-induced oxidative stress. BMC Complement Altern Med. 2014; 14: 111.
  18. Le May C, Chu K, Hu M, et al. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci U S A. 2006; 103(24): 9232–9237.
  19. Hossain Z, Valicherla GR, Gupta AP, et al. Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus. Sci Rep. 2018; 8(1): 8715.
  20. Bulboacă AE, Porfire AS, Tefas LR, et al. Liposomal Curcumin is Better than Curcumin to Alleviate Complications in Experimental Diabetic Mellitus. Molecules. 2019; 24(5).
  21. Chu Q, Moreland R, Yew NS, et al. Systemic Insulin-like growth factor-1 reverses hypoalgesia and improves mobility in a mouse model of diabetic peripheral neuropathy. Mol Ther. 2008; 16(8): 1400–1408.
  22. Kaur G, Padiya R, Adela R, et al. Garlic and Resveratrol Attenuate Diabetic Complications, Loss of β-Cells, Pancreatic and Hepatic Oxidative Stress in Streptozotocin-Induced Diabetic Rats. Front Pharmacol. 2016; 7: 360.
  23. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001; 50(6): 537–546.
  24. Kunnumakkara AB, Bordoloi D, Padmavathi G, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol. 2017; 174(11): 1325–1348.
  25. Pérez-López L, Boronat M, Melián C, et al. Study of the pathogenesis and treatment of diabetes mellitus through animal models. Endocrinol Nutr. 2016; 63(7): 345–353.
  26. Eleazu CO, Eleazu KC, Chukwuma S, et al. Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. J Diabetes Metab Disord. 2013; 12(1): 60.
  27. Pinney SE, Simmons RA. Epigenetic mechanisms in the development of type 2 diabetes. Trends Endocrinol Metab. 2010; 21(4): 223–229.
  28. Adewole SO, Ojewole JAO. Protective effects of Annona muricata Linn. (Annonaceae) leaf aqueous extract on serum lipid profiles and oxidative stress in hepatocytes of streptozotocin-treated diabetic rats. Afr J Tradit Complement Altern Med. 2008; 6(1): 30–41.
  29. Ilbey YO, Ozbek E, Cekmen M, et al. Protective effect of curcumin in cisplatin-induced oxidative injury in rat testis: mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways. Hum Reprod. 2009; 24(7): 1717–1725.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl